Novel nano-vaccine for melanoma developed 7 August 2019 | By Rachael Harper (Drug Target Review) A novel nano-vaccine has been developed which has proven effective in treating primary tumours and metastases that result from melanoma.
New drug could be used for targeted cancer therapies 7 August 2019 | By Rachael Harper (Drug Target Review) A new drug called IP1867B, which could be used for future treatments of brain tumours, is being examined.
Researchers grow genetically engineered mini livers to study disease 6 August 2019 | By Rachael Harper (Drug Target Review) The first genetically modified mini human livers have been grown in a laboratory, to emulate liver disease progression and test therapeutics.
Human stem cell combination could help damaged hearts live longer 6 August 2019 | By Rachael Harper (Drug Target Review) A combination of heart cells derived from human stem cells could lead to developing a treatment for heart failure.
New model predicts cognitive decline two years ahead 6 August 2019 | By Rachael Harper (Drug Target Review) Researchers hope the system can choose the right patients to enroll in clinical trials, to speed discovery of drug treatments.
New model can help translate mice research into human health results 5 August 2019 | By Rachael Harper (Drug Target Review) A new mouse model, called 'wildlings', has been developed which better mirrors human immune responses than standard laboratory mice.
Experimental treatment slows prion disease 5 August 2019 | By Rachael Harper (Drug Target Review) A new experiment has not only slowed the progression of the prion disease, scrapie, it also extended the lives of prion-infected mice
Protective protein guards against DNA damage 5 August 2019 | By Rachael Harper (Drug Target Review) It has been discovered that Polo-like kinase (PLK1) guards against severe DNA damage and could help target fast-growing cancer cells.
Allergy-driving cells identified as potential drug targets 2 August 2019 | By Victoria Rees (Drug Target Review) Researchers have discovered a subtype of immune cells that contribute to allergic reactions and anaphylaxis, providing a drug target.
Study reveals cancer cell fuelling mechanism 2 August 2019 | By Victoria Rees (Drug Target Review) Researchers have identified the process behind cancer cell energy production, providing a drug target for treatments to inhibit growth.
Molecular Devices introduces the FLIPR® Penta system 2 August 2019 | By Molecular Devices Molecular Devices, LLC, today announced the launch of the next generation of its FLIPR® Penta High-Throughput Cellular Screening System.
OX40-expressing follicular helper T cells can control rheumatoid arthritis 1 August 2019 | By Rachael Harper (Drug Target Review) New study shows that a subset of follicular helper T cells contributes to the hyposialylation of autoantibodies in rheumatoid arthritis.
Antibody therapy extends survival in mice with pancreatic cancer 1 August 2019 | By Rachael Harper (Drug Target Review) Scientists have found a way to target and knock out a protein which is widely involved in pancreatic cancer cell growth, survival and invasion.
Cancer cell nutrient pathway mechanism discovered 1 August 2019 | By Victoria Rees (Drug Target Review) Researchers have discovered the mechanism behind a gateway into cells for glutamine, illuminating potential ways to prevent cancer cells from getting nutrients.
Motor neuron disease electrical signalling pathways mapped 1 August 2019 | By Victoria Rees (Drug Target Review) A study has used EEG to investigate the neuron networks that act abnormally in the condition, providing a significant step in the search for treatments.
